American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$263M |
| 2 |
Church & Dwight Co
CHD
|
+$176M |
| 3 |
Lattice Semiconductor
LSCC
|
+$159M |
| 4 |
UnitedHealth
UNH
|
+$159M |
| 5 |
Meta Platforms (Facebook)
META
|
+$138M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$314M |
| 2 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$243M |
| 3 |
Air Products & Chemicals
APD
|
+$201M |
| 4 |
HES
Hess
HES
|
+$194M |
| 5 |
Visa
V
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.39% |
| 2 | Financials | 13.48% |
| 3 | Healthcare | 12.47% |
| 4 | Consumer Discretionary | 12.31% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EPIX
2701
DELISTED
ESSA Pharma
EPIX
| $132K | ﹤0.01% |
+20,044
| New | +$98.7K |
|
2702
Zegna
ZGN
$3.76B
| $132K | ﹤0.01% |
11,413
| – | – |
|
2703
SGHC Ltd
SGHC
$6.51B
| $130K | ﹤0.01% |
41,161
-105,221
| -72% | -$354K |
|
2704
Codexis
CDXS
$172M
| $130K | ﹤0.01% |
42,749
+14,748
| +53% | +$31.7K |
|
2705
Custom Truck One Source
CTOS
$2.46B
| $130K | ﹤0.01% |
21,093
+8,080
| +62% | +$47.7K |
|
2706
Sight Sciences
SGHT
$456M
| $129K | ﹤0.01% |
24,934
+9,026
| +57% | +$27.9K |
|
2707
Erasca
ERAS
$6.45B
| $129K | ﹤0.01% |
60,334
+19,924
| +49% | +$42K |
|
|
VTNR
2708
DELISTED
Vertex Energy, Inc
VTNR
| $128K | ﹤0.01% |
+37,849
| New | +$149K |
|
2709
Sabre
SABR
$831M
| $127K | ﹤0.01% |
28,977
-25,315
| -47% | -$97.7K |
|
|
ETNB
2710
DELISTED
89bio
ETNB
| $127K | ﹤0.01% |
+11,363
| New | +$104K |
|
2711
Ribbon Communications
RBBN
$372M
| $126K | ﹤0.01% |
43,396
+3,903
| +10% | +$8.79K |
|
|
ACCD
2712
DELISTED
Accolade Inc
ACCD
| $125K | ﹤0.01% |
10,397
-10,930
| -51% | -$93.6K |
|
2713
TScan Therapeutics
TCRX
$50.5M
| $124K | ﹤0.01% |
21,315
+2,103
| +11% | +$9.63K |
|
2714
Janux Therapeutics
JANX
$1.02B
| $123K | ﹤0.01% |
+11,443
| New | +$99K |
|
2715
Ponce Financial Group
PDLB
$500M
| $123K | ﹤0.01% |
12,555
+2,117
| +20% | +$18.3K |
|
2716
Zevra Therapeutics
ZVRA
$679M
| $122K | ﹤0.01% |
18,683
+1,004
| +6% | +$4.7K |
|
|
INZY
2717
DELISTED
Inozyme Pharma
INZY
| $122K | ﹤0.01% |
28,695
+10,622
| +59% | +$37.7K |
|
|
RDNW
2718
RideNow Group
RDNW
$245M
| $121K | ﹤0.01% |
+14,895
| New | +$95.5K |
|
|
SOL
2719
DELISTED
Emeren Group
SOL
| $121K | ﹤0.01% |
44,262
-3,379
| -7% | -$8.93K |
|
2720
The Honest Company
HNST
$544M
| $119K | ﹤0.01% |
+36,038
| New | +$65.7K |
|
|
API
2721
Agora
API
$379M
| $118K | ﹤0.01% |
44,747
+1,434
| +3% | +$4K |
|
2722
Axogen
AXGN
$2.67B
| $115K | ﹤0.01% |
+16,902
| New | +$94K |
|
2723
Verrica Pharmaceuticals
VRCA
$87.4M
| $115K | ﹤0.01% |
1,570
+42
| +3% | +$1.73K |
|
2724
Five Point Holdings
FPH
$372M
| $114K | ﹤0.01% |
37,239
-209
| -0.6% | -$548 |
|
2725
Ranpak Holdings
PACK
$464M
| $114K | ﹤0.01% |
19,592
+3,871
| +25% | +$16.4K |
|
Similar funds
American Century Companies's Q4 2023 Portfolio in Review
As of Q4 2023, American Century Companies held 2,961 positions worth $145B, up 12% from $130B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
American Century Companies's Q4 2023 filing shows 141 new, 1,802 increased, 780 reduced and 86 closed positions. Its largest new stake was Nextpower Inc: 1,286,526 shares worth $60.3M. The largest sale was Humana, an estimated $314M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q4 2023 buy was Nextpower Inc: 1,286,526 shares worth $60.3M.
- American Century Companies added most to Salesforce in Q4 2023, an estimated $263M increase.
- American Century Companies's biggest Q4 2023 reduction was Humana, cutting an estimated $314M.
- American Century Companies fully exited Earthstone Energy Inc. Class A Common Stock in Q4 2023, selling an estimated $58.9M.
- American Century Companies's ten largest holdings make up 23% of its $145B portfolio in Q4 2023.
- American Century Companies opened 141 new positions and closed 86 in Q4 2023.
- American Century Companies's portfolio value rose 12% quarter-over-quarter to $145B.
Based on American Century Companies's 13F filing for Q4 2023, filed 13 Feb 2024.